PharmaCyte Biotech, Inc. (PMCB) earnings
Quarterly results of PharmaCyte Biotech, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
PharmaCyte Biotech, Inc. is expected to report around December 17, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q1 FY2027
In Q1 FY2027 (ended July 31, 2026) PharmaCyte Biotech, Inc. reported revenue of $0 and a net loss of $5.1M.
Diluted earnings per share were -$0.54.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q1 FY2027 | $0 | - | -$5.1M | -$0.54 |
| Q4 FY2026 | $0 | - | -$4.4M | - |
| Q3 FY2026 | $0 | - | $746.9K | -$0.17 |
| Q2 FY2026 | $0 | - | -$7.4M | -$1.24 |
| Q1 FY2026 | $0 | - | -$8.4M | -$1.23 |
| Q4 FY2025 | $0 | - | $11.7M | - |
| Q3 FY2025 | $0 | - | -$3M | -$0.44 |
| Q2 FY2025 | $0 | - | -$1.5M | -$0.39 |
Results filings
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
When is PharmaCyte Biotech, Inc.'s next earnings date?
PharmaCyte Biotech, Inc. is expected to report around December 17, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were PharmaCyte Biotech, Inc.'s latest quarterly results?
For Q1 FY2027, which ended July 31, 2026, PharmaCyte Biotech, Inc. reported revenue of $0 and a net loss of $5.1M. The figures come from its filing with the SEC.
Get an email when PMCB reports
Follow PMCB and we email you its next results the day they are filed, with the numbers explained.